Balance Sheet Data

FibroGen, Inc. (FGEN)

$1.85

+0.03 (+1.65%)

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Actual
2024
Projected
2025
Projected
2026
Projected
2027
Projected
2028
Projected
Total Cash 533.76686.54405.19422.01235.59333.16305.65280.41257.26236.02
Total Cash (%)
Account Receivables 28.4541.8817.4016.3012.5516.8915.5014.2213.0511.97
Account Receivables (%)
Inventories 6.8916.5331.0140.4441.5722.2620.4218.7317.1915.77
Inventories (%)
Accounts Payable 6.0924.7926.1030.7617.9616.6815.3014.0412.8811.82
Accounts Payable (%)
Capital Expenditure -5.76-3.99-30.19-38.74-2.52-12.63-11.58-10.63-9.75-8.94
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.